Toggle navigation
Browse
Home
People
Departments & Colleges
Research
Research Area Overlaps
Hypofractionated-intensity modulated radiotherapy (hypo-IMRT) and temozolomide (TMZ) with or without bevacizumab (BEV) for newly diagnosed glioblastoma multiforme (GBM): a comparison of two prospective phase II trials
Article (Web of Science)
Overview
Research
Additional Document Info
View All
Overview
cited authors
Carlson, Julie A.; Reddy, Krishna; Gaspar, Laurie E.; Ney, Douglas; Kavanagh, Brian D.; Damek, Denise; Lillehei, Kevin; Chen, Changhu
publication date
June 1, 2015
webpage
Web of Science
published in
JOURNAL OF NEURO-ONCOLOGY
Journal
Research
author keyword
Bevacizumab
GBM
Glioblastoma multiforme
Intensity modulated radiation therapy
category
CLINICAL NEUROLOGY
Category
Additional Document Info
start page
251
end page
257
volume
123
issue
2